Monday, August 2, 2010

• N30 Pharma Announces FDA Approval to Initiate Phase 1 Clinical Trial for First-in-Class Drug --- BOULDER, Colo., Aug. 2
  Posted at 5:00 AM
  N30 Pharmaceuticals, LLC today announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration. N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR), has the potential to be an important new treatment for acute exacerbations of asthma, chronic obstructive pulmonary disease (COPD) and inflammatory bowel disease (IBD). N30 Pharma will now begin a first-in-man, Phase 1, dose escalation trial of N6022 in healthy subjects. The trial will assess the safety ... read more
• Haemonetics Announces Agreement with Consorta, Inc. for New Blood Management Business Intelligence Portal --- BRAINTREE, Mass., Aug. 2
  Posted at 5:00 AM
  Haemonetics Corporation (NYSE: HAE) announced an agreement with Consorta, Inc., one of the nation's leading healthcare resource management and group purchasing organizations (GPO), to provide IMPACT(TM) Online, Haemonetics' new blood management business intelligence portal, to Consorta's member hospitals. IMPACT Online will provide Consorta member hospitals with the ability to access information related to their blood supply operations in order to better measure hospital blood use and clinical outcomes on a regular basis. The agreement is ... read more
• Tengion Appoints A. Brian Davis Chief Financial Officer --- EAST NORRITON, Pa., Aug. 2
  Posted at 5:00 AM
  Tengion Inc. (Nasdaq: TNGN) today announced that it has appointed A. Brian Davis to the position of Chief Financial Officer. Mr. Davis comes to Tengion after 15 years with Neose Technologies, Inc., a biopharmaceutical company using enzymatic technologies to develop improved protein therapeutics. At its peak, Neose employed 200 individuals, including cGMP production, development and research personnel at three sites. "Brian's demonstrated excellence as a public biotech company CFO, his strong accounting and finance background, and his experience supporting ... read more
• MultiCell Technologies Applies for Qualifying Therapeutic Discovery Project Grants --- WOONSOCKET, R.I., Aug. 2
  Posted at 5:00 AM
  MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announces it has submitted four separate grant applications under the U.S. government's Qualifying Therapeutic Discovery Project ("QTDP"). The QTDP was created by Congress as part of the Patient Protection and Affordable Care Act, and provides a tax credit or grant equal to eligible costs and expenses for tax years 2009 and 2010. The Company submitted grant applications for its therapeutic development projects MCT-125, MCT-465, MCT-475 and MCT-485. To be eligible, a project ... read more
• EDAC Technologies Awarded $5.3 Million Rotorcraft Parts Contract --- FARMINGTON, Conn., Aug. 2
  Posted at 5:00 AM
  EDAC Technologies Corporation (Nasdaq: EDAC), a diversified designer, manufacturer and servicer of precision components for aerospace and industrial applications, today announced that it has signed a multi-year agreement to supply a major rotating component for a leading manufacturer of rotorcraft. The agreement has an initial term of three years, with an option for an additional two-year extension, and is valued at approximately $5.3 million during the initial three-year period. The Company noted that with this agreement its backlog has increased ... read more
• Motorola's Mission Critical Wireless Earpiece Delivers Secure and Robust Bluetooth® Communications for First Responders --- HOUSTON, Aug. 2
  Posted at 5:00 AM
  (APCO, Motorola Booth # 531) -- The Enterprise Mobility Solutions business of Motorola, Inc. (NYSE: MOT) today announced Motorola's first encrypted mission critical Bluetooth earpiece enabling secure communications when paired with the Motorola APX(TM)-series portable radios. Designed specifically for the needs of first responders, Motorola's Mission Critical Wireless Earpiece provides simple pairing and fast push-to-talk enabling every word to be said and heard. The earpiece also performs in strenuous environments and has been optimized to provide loud, clear audio in noisy conditions, ... read more
• Motorola Enables Seamless Communications Across Public Safety Agencies and Jurisdictions by Offering Multiple Choices for Interoperability --- HOUSTON, Aug. 2
  Posted at 5:00 AM
  (APCO, Motorola Booth # 531) The Enterprise Mobility Solutions business of Motorola, Inc. (NYSE: MOT) today announced it is delivering on its Next Generation Public Safety plan launched earlier this year. By providing first responders with several interoperability options, Motorola helps ensure seamless communications across public safety agencies and jurisdictions so they can effectively coordinate a joint response. The interoperability technology highlighted at the Association of Public-Safety Communications Officials-International, Inc. (APCO) Annual Conference and Exposition, include Project 25 Multi-band radios, Project ... read more
• Motorola Introduces Additions to APX P25 Mission Critical Two-Way Radio Series --- HOUSTON, Aug. 2
  Posted at 5:00 AM
  (APCO, Motorola Booth # 531) -- The Enterprise Mobility Solutions business of Motorola, Inc. (NYSE: MOT) today announced its newest additions to its APX P25 mission critical two-way radio series --the APX(TM) 7000XE Portable, APX(TM) 6000 Portable and APX(TM) 6500 Mobile. All radios in the Motorola APX series are P25 Phase 2 capable and designed to redefine safety for first responders with best-in-class features, functionality and design. The APX 7000XE, the first Motorola radio designed for use by first responders in ... read more
• Motorola Launches MVX1000 In-Car Digital Video System for Next Generation Mission Critical Applications for Law Enforcement --- HOUSTON, Aug. 2
  Posted at 5:00 AM
  APCO, Motorola Booth # 531 -- The Enterprise Mobility Solutions business of Motorola, Inc. (NYSE: MOT) today announces the launch of the MVX1000, a next generation, in-car digital video system designed to capture critical evidence and protect law enforcement officers from spurious false charges. The rugged MVX1000 delivers intuitive, high-performance in-vehicle evidence capture and back office management capabilities for law enforcement officers. In addition, the system seamlessly integrates captured video into a database, making it easily searchable and shareable with prosecutors ... read more
• Poniard Pharmaceuticals to Host Second Quarter 2010 Financial Results Conference Call --- SOUTH SAN FRANCISCO, Calif., Aug. 2
  Posted at 5:00 AM
  Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that it will hold a conference call on Monday, August 9, 2010 to discuss the Company's second quarter 2010 financial results and provide a corporate update. Management will host the call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). A press release highlighting results for the second quarter 2010, will be released prior to the conference call on August 9, 2010. To ... read more
• Cornerstone Therapeutics Announces Collaboration with The Cough Company --- CARY, N.C., Aug. 2
  Posted at 5:00 AM
  Cornerstone Therapeutics Inc. (Nasdaq: CRTX) ("Cornerstone" or the "Company"), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has entered into a License Agreement and a Development Agreement with Alitair Pharmaceuticals, Inc, also known as The Cough Company ("The Cough Company"). Under the terms of the agreement, Cornerstone has acquired a license to certain of The Cough Company's proprietary intellectual property and the companies ... read more
• BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform --- FRANKLIN LAKES, N.J., Aug. 2
  Posted at 5:00 AM
  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of the sale of its Ophthalmic Systems unit to RoundTable Healthcare Partners and the sale of its surgical blades product platform to one of RoundTable's portfolio companies, Aspen Surgical Products, Inc. On June 8, 2010, the Company announced that it had signed agreements to sell certain assets of its BD Medical segment, including the Ophthalmic Systems unit as well as the surgical blades, ... read more
• CSG Government Solutions Selected for State of Iowa HIPAA Modernization Contract --- CHICAGO, Aug. 2
  Posted at 5:00 AM
  CSG Government Solutions, a national leader in providing public sector strategy, quality management and systems modernization services, today announced that it has been awarded a multi-year contract by the Iowa Department of Human Services to provide a full suite of HIPAA compliance management services. CSG Government Solutions will leverage its transformational REALize-HIPAA methodology to provide full life cycle support for the Iowa Medicaid Enterprise HIPAA Transactions and Code Sets (TCS) Compliance Project. The project includes migration tasks to implement X12 ... read more
• The Majority of Surveyed Gastroenterologists Prescribe Humira Off-Label for the Treatment of Ulcerative Colitis --- WALTHAM, Mass., Aug. 2
  Posted at 5:00 AM
  Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 63 percent of surveyed U.S. gastroenterologists prescribe Abbott's Humira off-label for the treatment of ulcerative colitis. According to the new report entitled Treatment Algorithms in Ulcerative Colitis, surveyed gastroenterologists most often prescribe Humira for ulcerative colitis for patients with loss of response, intolerance or no response to Centocor Ortho Biotech's Remicade. Analysis of patient-level claims data finds that Humira is also prescribed ... read more
• Haemonetics Reports Adjusted Earnings per Share of $0.74 for Q1 of Fiscal 11 Company Affirms Full Year Guidance --- BRAINTREE, Mass., Aug. 2
  Posted at 5:00 AM
  Haemonetics Corporation (NYSE: HAE) today reported GAAP net revenues of $163 million, up 6%, net income of $18 million, down 1%, and earnings per share of $0.70, up 1%. Excluding transformation costs in fiscal 11, adjusted first quarter net income was $19 million, up 5%, and adjusted earnings per share was $0.74, up 7%. In constant currency, revenue was up 8%, adjusted net income was up 30% and adjusted earnings per share were up 32%. (1) As expected, the quarterly ... read more
• CardioMag Imaging Receives Patents From the United States and China --- SCHENECTADY, N.Y., Aug. 2
  Posted at 5:00 AM
  CardioMag Imaging, Inc. (CMI) is pleased to announce receipt of two (2) additional patents; one in the United States and one in China to protect key aspects of its technology that can, non-invasively, safely, rapidly and more reliably than ECG, detect early symptoms of Heart Disease without the use of injections or Radiation. The U.S. Patent, entitled USE OF MACHINE LEARNING FOR CLASSIFICATION OF MAGNETO CARDIOGRAMS, was applied for on July 1, 2003, while the patent application for China was submitted ... read more
• Haemonetics Announces Future Retirement Date of Board Chairman Brad Nutter --- BRAINTREE, Mass., Aug. 2
  Posted at 5:00 AM
  Haemonetics Corporation (NYSE: HAE) announced today that Brad Nutter will retire as Executive Chairman of the Board effective November 1, 2010. Mr. Nutter's retirement marks the end of the CEO succession plan that began with the announcement in October, 2008 that Brian Concannon, then Chief Operating Officer, would replace Brad Nutter as President and CEO and Brad Nutter would assume the role of Executive Chairman of the Board. Brian Concannon was appointed President and CEO as of April ... read more
• Sagent Pharmaceuticals Announces Two New FDA Approvals: Sumatriptan Succinate Injection and Rocuronium Bromide Injection --- SCHAUMBURG, Ill., Aug. 2
  Posted at 5:00 AM
  Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and rocuronium bromide injection. Sumatriptan succinate injection (sumatriptan) will be available in 6 mg per 0.5 mL latex-free vials. Rocuronium bromide injection will be available in latex-free vials of 50 mg per 5 mL and 100 mg per 10 mL. According to 2009 IMS data, the U.S. market for injectable sumatriptan approximated $22 million and $59 million for rocuronium. "The addition of sumatriptan and ... read more
• Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010 --- SAN FRANCISCO, Aug. 2
  Posted at 5:00 AM
  Medivation, Inc. (Nasdaq: MDVN) today announced that it will host a teleconference and webcast with management to discuss second quarter 2010 financial results and provide a general business update on August 9, 2010, at 4:30 p.m. Eastern Time. A press release for the second quarter ended June 30, 2010 will be released after markets close on August 9, 2010. Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals interested in listening to the live call via webcast may ... read more
• Puerto Rico's Sistema University Ana G. Mendez (SUAGM) Selects Ruckus for Massive, 802.11n Indoor/Outdoor Wireless Network --- SUNNYVALE, Calif., Aug. 2
  Posted at 5:00 AM
  Ruckus Wireless(TM) today announced that the Sistema University Ana G. Mendez (SUAGM), one of the largest university systems in Puerto Rico, has selected the Ruckus ZoneFlex Smart Wireless LAN (WLAN) system for a large-scale, indoor/outdoor Wi-Fi infrastructure spanning campuses and satellite locations throughout Puerto Rico and Florida. The new Ruckus Smart Wi-Fi network will support over 40,000 students and staff and replaces hundreds of legacy Wi-Fi access points (APs). The new 802.11n network is being deployed in phases across SUAGM's three ... read more